Alzheon
Cyril Höschl is on the Board of Advisors at Alzheon.
This person is not in the org chart
This person is not in any offices
Alzheon
Alzheon is committed to developing innovative medicines by directly addressing the underlying pathology of devastating neurodegenerative disorders.